Pastila inspirată de sport, testată pe oameni. Medicamentul ar putea ajuta la menținerea greutății şi reduce pofta de mâncare

A biotechnology company is testing an oral medication, ENV-308, designed to mimic exercise-induced signals in the body. Initial human trials show it is well tolerated but do not confirm weight loss effects. The drug targets leptin, a hormone involved in appetite regulation, and aims to help maintain weight after GLP-1 treatments. Future studies will focus on its impact on weight and appetite, particularly in individuals who have stopped GLP-1 medications.